Emergent BioSolutions (EBS) EV to FCF (2011 - 2026)
Emergent BioSolutions' (EBS) EV to FCF was 0.86 for Q3 2026, down 99.4% from 156.65 a year earlier and down 74.4% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) EV to FCF (2011 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Emergent BioSolutions' EV to FCF came in at -1.82; for FY2025, it was 2.80, down 76.1% from FY2024.
- By year, EV to FCF came in at 11.72 in FY2024 and 17.21 in FY2021 (+64.3%).
- The Q3 2026 figure ranks as the lowest quarterly EV to FCF since Q2 2025.
- Year over year, EV to FCF gained in two of the last five quarters, with growth averaging 77.7%.
- The high point for year-over-year EV to FCF in five years was Q2 2026 (growth of 595.3%); the low point was Q3 2026 (a decline of 99.4%).
- Per Business Quant data, the three quarters before Q3 2026 came in at 3.38 (Q2 2026), 1.99 (Q1 2026) and 2.80 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.86 |
| Jun 30, 2026 | 3.38 |
| Mar 31, 2026 | 1.99 |
| Dec 31, 2025 | 2.80 |
| Sep 30, 2025 | 156.65 |
| Jun 30, 2025 | 0.49 |
| Mar 31, 2025 | 1.23 |
| Dec 31, 2024 | 11.72 |
| Sep 30, 2024 | 2.19 |
| Jun 30, 2024 | 7.74 |
| Jun 30, 2022 | 9.41 |
| Mar 31, 2022 | 21.05 |
| Dec 31, 2021 | 17.21 |
| Sep 30, 2021 | 99.78 |
| Jun 30, 2021 | 24.28 |
| Mar 31, 2021 | 14.28 |
| Dec 31, 2020 | 10.47 |
| Sep 30, 2020 | 18.62 |
| Jun 30, 2020 | 20.18 |
| Mar 31, 2020 | 55.45 |
API Access
Emergent BioSolutions EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();